Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Allograft Recipients”

163 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 163 results

Not applicableStudy completedNCT00288977
What this trial is testing

Islet Transplantation in Type 1 Diabetic Recipients of Kidney Transplants

Who this might be right for
DiabetesKidney Transplantation
Beth Israel Deaconess Medical Center 8
Testing effectiveness (Phase 2)Looking for participantsNCT07290777
What this trial is testing

VEL-101 to Prevent Rejection After Kidney Transplantation

Who this might be right for
Transplantation, Kidney
Veloxis Pharmaceuticals 120
Testing effectiveness (Phase 2)Study completedNCT03663335
What this trial is testing

Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 418
Testing effectiveness (Phase 2)UnknownNCT00498160
What this trial is testing

Induction of Donor Specific Tolerance in Recipients of Live Donor Kidney Allografts by Donor Stem Cell Infusion

Who this might be right for
Renal Failure
Talaris Therapeutics Inc. 38
Early research (Phase 1)WithdrawnNCT07100925
What this trial is testing

Tolododekin Alfa (ANK-101) in Renal Allograft Recipients With High Risk Cutaneous Squamous Cell Carcinoma

Who this might be right for
Cutaneous Squamous Cell Carcinoma (CSCC)Renal TransplantSolid Tumor+1 more
Ankyra Therapeutics, Inc
Post-approval studies (Phase 4)Looking for participantsNCT04989491
What this trial is testing

Evaluation of the Efficacy of a Treatment by One Single Dose of Rituximab (375mg/m2 ) in the Prevention of the Epstein Barr Virus (EBV) Primary Infection and Post-transplant Lymphoproliferative Disorder in Adult EBV Seronegative Patients Who Received an EBV Seropositive Kidney Allograft

Who this might be right for
Epstein-Barr Virus Infections
University Hospital, Strasbourg, France 120
Post-approval studies (Phase 4)Study completedNCT01265615
What this trial is testing

Paricalcitol Versus Calcitriol for the Management of Renocardiac Syndrome in Renal Transplant Patients

Who this might be right for
Cardiorenal SyndromeChronic Allograft Nephropathy
Ural State Medical University 109
Not applicableActive Not RecruitingNCT05477082
What this trial is testing

Blood Biomarkers in Pediatric Kidney Transplant Recipients

Who this might be right for
Rejection of Kidney Allograft
University of Minnesota 27
Not applicableLooking for participantsNCT07181096
What this trial is testing

Frailty Among Renal Transplant Recipients and Relation to Chronic Allograft Dysfunction

Who this might be right for
FrailtyRenal Transplant
Alexandria University 80
Not applicableStudy completedNCT01653847
What this trial is testing

Study in Recipients of Renal Transplant Allograft to Evaluate the Impact of Two Immunosuppressive Regimens

Who this might be right for
End Stage Renal Failure With Renal Transplant
Northwestern University 88
Large-scale testing (Phase 3)Study completedNCT01150097
What this trial is testing

Extension Study to Evaluate the Long-term Efficacy and Safety of Everolimus in Liver Transplant Recipients

Who this might be right for
Liver Transplant Recipient
Novartis Pharmaceuticals 284
Post-approval studies (Phase 4)Study completedNCT00121810
What this trial is testing

Kidney Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Hoffmann-La Roche 305
Testing effectiveness (Phase 2)Study completedNCT00658359
What this trial is testing

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Who this might be right for
Kidney Transplantation
Pfizer 178
Not applicableStudy completedNCT02555566
What this trial is testing

Role of Epoxyeicosatrienoic Acids in Chronic Allograft Nephropathy - The TRANSPLANT-EETs Study

Who this might be right for
Kidney Transplant Recipients
University Hospital, Rouen 80
Post-approval studies (Phase 4)Study completedNCT00275535
What this trial is testing

The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients

Who this might be right for
Kidney Diseases
Mayo Clinic 165
Early research (Phase 1)Study completedNCT03504241
What this trial is testing

Tolerance by Engaging Antigen During Cellular Homeostasis

Who this might be right for
Kidney TransplantationRenal TransplantationRenal Transplant Recipient
National Institute of Allergy and Infectious Diseases (NIAID) 8
Post-approval studies (Phase 4)Study completedNCT00782821
What this trial is testing

Randomized Trial of Induction Therapies in High Immunological Risk Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
University of Cincinnati 40
Post-approval studies (Phase 4)UnknownNCT00541814
What this trial is testing

Calcineurin Inhibitor Minimisation in Renal Transplant Recipients With Stable Allograft Function

Who this might be right for
Chronic Allograft Nephropathy
University Hospital Birmingham 90
Post-approval studies (Phase 4)Study completedNCT01371331
What this trial is testing

Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ Transplantation

Who this might be right for
Kidney TransplantationHeart TransplantationLiver Transplantation
Astellas Pharma Europe Ltd. 52
Not applicableLooking for participantsNCT07333495
What this trial is testing

A Mixed Cohort, Multicentre Exploratory Study of Non-invasive Quantitative Assessment of Renal Graft Function With Non-contrast Functional Magnetic Resonance Imaging

Who this might be right for
Kidney TransplantRenal Allograft RecipientsRenal Allograft
Tongji Hospital 1,000
Next Page